Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome

Arthritis Rheum. 2004 Oct;50(10):3260-4. doi: 10.1002/art.20551.

Abstract

Arterial thrombotic events, thrombocytopenia, and hemolytic anemia with schistocytes may be encountered in the setting of both thrombotic thrombocytopenic purpura (TTP) and primary antiphospholipid syndrome (APS). We report 2 cases of TTP occurring in patients with definite primary APS. We also describe the results of tests for ADAMTS-13 activity in 20 consecutive patients with primary APS, as well as tests for antiphospholipid antibodies in 26 patients who had TTP, severe ADAMTS-13 deficiency, and ADAMTS-13-inhibiting antibodies. In both of the patients with primary APS and TTP, ADAMTS-13 activity was undetectable, and ADAMTS-13-inhibiting antibodies were present. None of the 26 patients with TTP and severe ADAMTS-13 deficiency was positive for the lupus anticoagulant. One of these patients had a low level of anticardiolipin antibodies (22 IgG phospholipid units). In the 20 patients with primary APS, mean ADAMTS-13 activity was 116% (range 44-250%), and no severe deficiency (< 5%) was observed. Our findings suggest that primary APS must be added to the list of autoimmune disorders that can be complicated by TTP.

Publication types

  • Case Reports

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adolescent
  • Adult
  • Antibodies, Anticardiolipin / blood
  • Antiphospholipid Syndrome / complications*
  • Female
  • Humans
  • Lupus Coagulation Inhibitor / analysis
  • Metalloendopeptidases / deficiency*
  • Metalloendopeptidases / immunology
  • Purpura, Thrombotic Thrombocytopenic / complications*

Substances

  • Antibodies, Anticardiolipin
  • Lupus Coagulation Inhibitor
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human